Antengene Corporation Limited (6996.HK)
| Previous close | 0.810 |
| Open | 0.800 |
| Bid | 0.810 x N/A |
| Ask | 0.820 x N/A |
| Day's range | 0.790 - 0.810 |
| 52-week range | 0.770 - 2.250 |
| Volume | |
| Avg. volume | 345,244 |
| Market cap | 546.66M |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.010 |
| Earnings date | 23 Aug 2024 - 27 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.60 |
PR NewswireAntengene To Present One Oral and Four Abstracts at ASCO 2024
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced one oral presentation, three poster presentations and a journal publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 31st to June 4th at the McCormick Place Convention Center in Chica
- PR Newswire
Antengene Announces One Oral and Three Poster Presentations at ASCO 2024
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced the presentation of four abstracts (including one oral presentation and three poster presentations) at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting, taking place from May 31st to June 4th at the McCormick Place C
PR NewswireAntengene Presents Four Preclinical Posters at AACR 2024
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced the presentation of four preclinical posters at the 2024 American Association for Cancer Research Annual Meeting (AACR 2024), taking place from April 5th to April 10th at the San Diego Convention Center in San Diego, California, the Unit
